{"schema_version":"secwatch.filing_event.v1","accession":"0001601830-25-000088","form_type":"8-K","ticker":"RXRX","cik":"0001601830","company_name":"RECURSION PHARMACEUTICALS, INC.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.971679+00:00","generated_at":"2026-05-19T02:59:25.769346+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Recursion Pharmaceuticals stockholders elect directors, approve exec comp, ratify auditor at 2025 meeting","bullets":["Elected Zachary Bogue (242.3M for, 4.0M withheld), Zavain Dar (203.3M for, 42.9M withheld), Robert Hershberg (233.5M for, 12.8M withheld) as Class I directors.","Advisory resolution to approve executive compensation approved with 239.9M for, 3.2M against, 3.1M abstain, 93.4M broker non-votes.","Ratification of PwC as independent auditor for FY2025 approved with 334.6M for, 2.0M against, 3.1M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001601830-25-000088","json":"https://secwatch.observer/filing/0001601830-25-000088.json","markdown":"https://secwatch.observer/filing/0001601830-25-000088.md","text":"https://secwatch.observer/filing/0001601830-25-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000088/0001601830-25-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601830/000160183025000088/rxrx-20250618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:59:25.769346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}